Lilly Endowment Inc |
10%+ Owner |
$93.9B |
-$2.35B |
-2.44% |
Sep 3, 2024 |
David A. Ricks |
President, Chair, and CEO, Director |
$577M |
|
|
Aug 20, 2024 |
Daniel Skovronsky |
EVP, CSO & Pres. LRL & LLY Imm |
$194M |
|
|
Sep 10, 2024 |
Stephen F. Fry |
SVP, HR & Diversity |
$101M |
|
|
Feb 9, 2022 |
J. Erik Fyrwald |
Director |
$52.8M |
|
|
Nov 18, 2024 |
Anne E. White |
EVP & Pres, Lilly Neuroscience |
$50.8M |
|
|
Feb 12, 2024 |
Jackson P. Tai |
Director |
$40.3M |
|
|
Apr 17, 2023 |
Ralph Alvarez |
Director |
$39.7M |
|
|
Nov 18, 2024 |
Patrik Jonsson |
EVP&Pres, LLY Dia&Obe, LLY USA |
$35.8M |
|
|
Feb 12, 2024 |
Anat Ashkenazi |
Evp & Cfo |
$35M |
|
|
Feb 12, 2024 |
Anat Hakim |
EVP, GC & Secretary |
$32.6M |
|
|
Aug 12, 2024 |
Michael L. Eskew |
Director |
$28.6M |
|
|
Nov 15, 2021 |
Edgardo Hernandez |
EVP & Pres., Mfg. Operations |
$27.9M |
|
|
Nov 1, 2024 |
Michael B. Mason |
EVP & Pres., Lilly Diabetes |
$27.6M |
|
|
Feb 10, 2023 |
Johna Norton |
EVP, Global Quality |
$23.7M |
-$5.78M |
-19.6% |
Jun 3, 2024 |
Leigh Ann Pusey |
EVP, Corp. Affairs & Comm. |
$21.1M |
|
|
Feb 10, 2023 |
Jacob Van Naarden |
EVP & Pres., Lilly Oncology |
$20.8M |
|
|
Oct 31, 2024 |
Ilya Yuffa |
EVP & President, LLY Int'l |
$17M |
|
|
Feb 12, 2024 |
Katherine Baicker |
Director |
$16.8M |
|
|
Nov 18, 2024 |
William G. Kaelin Jr |
Director |
$15.6M |
|
|
Nov 18, 2024 |
Gordon J. Brooks |
Interim CFO, Group VP |
$15.3M |
|
|
Jul 15, 2024 |
Juan R. Luciano |
Director |
$11.7M |
|
|
Nov 18, 2024 |
Marschall S. Runge |
Director |
$10.5M |
|
|
Nov 20, 2023 |
Diogo Rau |
Evp & Cido |
$9.11M |
|
|
Jun 1, 2024 |
Lucas Montarce |
Evp & Cfo |
$9.07M |
|
|
Nov 1, 2024 |
Eric Dozier |
EVP, HR & Diversity |
$6.83M |
|
|
Nov 1, 2024 |
Jamere Jackson |
Director |
$6.66M |
|
|
Nov 18, 2024 |
Alonzo Weems |
Evp, Erm & Ceco |
$6.58M |
|
|
Feb 12, 2024 |
Donald A. Zakrowski |
SVP, Finance, & CAO |
$5.92M |
-$2.62M |
-30.6% |
Nov 8, 2024 |
Karen Walker |
Director |
$4.54M |
|
|
Nov 18, 2024 |
Melissa Seymour |
EVP, Global Quality |
$2.74M |
|
|
Aug 1, 2024 |
Kimberly H. Johnson |
Director |
$2.19M |
|
|
Nov 18, 2024 |
Gabrielle Sulzberger |
Director |
$1.83M |
|
|
Nov 18, 2024 |
Mary Lynne Hedley |
Director |
$1.43M |
|
|
Nov 18, 2024 |